-+ 0.00%
-+ 0.00%
-+ 0.00%

(AstraZeneca) shares rose 1% after a breast cancer drug developed jointly with Daiichi Sankyo was approved by the US Food and Drug Administration.

智通財經·12/16/2025 08:09:02
語音播報
(AstraZeneca) shares rose 1% after a breast cancer drug developed jointly with Daiichi Sankyo was approved by the US Food and Drug Administration.